The Illegal Sale of Nicotine E-Cigarettes in Australia

Regulations by 2FIRSTS.ai
Jan.10.2024
The Illegal Sale of Nicotine E-Cigarettes in Australia
Australia's ban on the sale of e-cigarettes containing nicotine is being openly ignored by shops in Sydney, according to the Health Ministry.

According to a report by the Daily Mail in Australia, the Ministry of Health has discovered that shops in the country's largest city openly defy the government's new ban and continue to sell nicotine e-cigarette products. The ban, which came into effect on January 1st, prohibits the import of disposable e-cigarettes and retailers are prohibited from selling e-cigarettes containing nicotine. The Minister of Health, Mark Butler, hailed this reform as "world-leading" and emphasized that "if you smoke e-cigarettes, the New Year's resolution is to quit." However, Butler's efforts seem to have gone up in smoke as they are being blatantly disregarded by various specialty stores and convenience stores.

 

At the trendy King Street in Newtown, Sydney, the Daily Mail has uncovered at least 20 independent and chain stores openly selling illegal nicotine e-cigarettes, illicit cigarettes, and other smoking devices. In some stores, reporters were presented with a plastic folder displaying dozens of different models and flavors for customers to choose from. These flavors include apple, blueberry, watermelon, and ice mango, despite the ban by the Butler government, indicating their nicotine content. The packaging of these products features bright colors and lively designs, making e-cigarettes resemble candies for children rather than nicotine products. Prices vary from $25 to $50 depending on the amount of inhalation capacity the e-cigarette possesses.

 

The process of purchasing these prohibited products is no different from buying legal goods. There is no identity verification to confirm age, and there are no secret whispers – just a straightforward credit card transaction in exchange for these banned items. Brian Marlow, the director supporting the legalization of e-cigarettes in Australia, revealed in an interview with the Daily Mail that this demonstrates the government's efforts to regulate e-cigarettes have been ineffective.

 

He stated, "The interesting aspect of this ban is that disposable e-cigarettes have never been legal in Australia and have always been prohibited."

 

He also mentioned that in 2021, the Morrison government banned any Australians from purchasing or importing nicotine e-cigarettes or e-cigarettes without a doctor's prescription. This aligns the import requirements with the regulations in Australian state and territorial laws that prohibit the sale of nicotine e-cigarettes.

 

However, many retailers and manufacturers are attempting to circumvent this regulation by falsely claiming that their products do not contain nicotine. Under the new ban, retailers are permitted to sell non-nicotine inventory imported prior to this year.

 

Starting from March 1st, the importation of all non-therapeutic e-cigarettes, as well as personal use e-cigarettes, will be prohibited. To comply with the changes in import regulations, a new access mechanism will be established, allowing doctors and nurses to prescribe therapeutic e-cigarettes in appropriate cases. Mr. Malo stated that these bans only permit retailers to charge higher prices for e-cigarettes due to the increased risks associated with importation and sales.

 

He also stated that criminal gangs which import e-cigarettes from China and sell them to retailers can increase their profits. He stated, "Over 90% of e-cigarettes sold in Australia are from the black market."

 

For over a million e-cigarette users in Australia, what you see is a multi-billion-dollar industry that the federal government has no concrete plans to legalize. He says, "We are the only country in the world facing such a serious issue.

 

Mr. Malo also stated that these addictive e-cigarettes, such as IGET, are manufactured in China but are banned and rarely used by residents there. He said, "But here, we are enthusiastic about using it, with no problem exporting it to Australia. Due to our lack of proper market regulation, people are willing to break the law and face criminal charges. They are willing to sell to children. We allow criminals to act." Malo said that market restrictions, product standards, retailer licenses, and heavy fines for selling to minors will help eliminate the black market.

 

Marlowe has suggested that Australia should follow the lead of New Zealand, the UK, and other parts of the world in regulating e-cigarettes. He stated, "Allow the sale of high-quality e-cigarettes and subject them to the same regulations as other adult-only products, such as alcoholic beverages."

 

By engaging in such actions, adults would be able to access safer products with higher nicotine levels than those potentially found in illicit disposable items in China.

 

This will also counter the rampant black market of e-cigarettes created by the government." However, Professor Simon Chapman, a public health expert at the University of Sydney, argues that strict regulations are necessary for e-cigarettes and opposes labeling reform as a 'ban'. He told the media, "E-cigarettes are not banned, they should just always be heavily regulated. Anyone claiming that e-cigarettes are banned may also believe that every prescription drug made in Australia is similarly banned."

 

The government is currently cracking down on the increased access to e-cigarettes by minors and the reasons why new non-smokers are starting to use nicotine e-cigarettes. Mr. Butler stated in his speech at the National Press Club in May 2023, "E-cigarettes are not recreational products, especially not for our children. This is the reality of e-cigarettes today.

 

Butler criticized the former coalition government, stating that while they established regulations for the import of e-cigarettes and sought legal prescriptions for smokers, they failed to strictly enforce these measures, thereby creating the perfect conditions for the rampant illegal market.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
The U.S. FDA has consolidated two tobacco establishment registration and product listing forms into a redesigned Form FDA 3741 covering all regulated product categories, including e-cigarettes, heated tobacco products and nicotine pouches. The current requirements remain limited to domestic establishments. Separately, the FDA has proposed extending registration and product listing requirements to foreign manufacturers, signaling greater regulatory attention to manufacturing entities and product-level information across the tobacco and nicotine supply chain.
FDA
Sep.30
Charlie’s Says 30 PACHA Vape SKUs Tentatively Identified for FDA’s Non-Priority Enforcement Public List
Charlie’s Says 30 PACHA Vape SKUs Tentatively Identified for FDA’s Non-Priority Enforcement Public List
Charlie’s Holdings said the U.S. Food and Drug Administration notified the company on June 23, 2026, that 30 PACHA vape SKUs with submitted PMTAs had been tentatively identified for inclusion on a planned public-facing FDA webpage. Under enforcement guidance issued by FDA in May, the webpage is intended to identify certain unauthorized products for which the agency generally does not intend to prioritize enforcement of premarket authorization requirements. Charlie’s disclosed the development alongside second-quarter revenue of $3.8 million, up 116% year over year.
Aug.25
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Capital is reassessing the global tobacco and modern nicotine industry as heated tobacco, vaping and nicotine pouches reshape demand, profitability and regulation. At the 2026 New Approaches Summit in New York, investors and analysts examined whether smoke-free growth can sustain earnings, how regulation shapes startup value, and whether shareholder engagement can be more effective than divestment. The debate points to a broader shift: tobacco transition is increasingly becoming a capital-allocation, governance and valuation question.
Capital Markets
Oct.05
Product | HQD SiSA 80K Enters the U.S. Market With a Hookah-Inspired Approach to the High-Capacity Disposable Segment
Product | HQD SiSA 80K Enters the U.S. Market With a Hookah-Inspired Approach to the High-Capacity Disposable Segment
The HQD SiSA 80K Hookah Disposable Vape has appeared across U.S. and cross-border online retail channels. The device comes prefilled with 28ml of e-liquid, uses a 5% nicotine salt configuration and carries a brand claim of up to 80,000 puffs. Beyond puff count, the product differentiates itself through hookah-inspired features including adjustable airflow, a flowing-water sound effect and flavor options associated with traditional hookah consumption.
Aug.18
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives